A Combined Histone Deacetylases Targeting Strategy to Overcome Venetoclax Plus Azacitidine Regimen Resistance in Acute Myeloid Leukaemia: Three Case Reports

The management of patients with relapsed or refractory (R/R) acute myeloid leukaemia (AML) remains a challenge with few reliably effective treatments. Chidamide, a new selective HDAC inhibitor, has demonstrated some effectiveness in AML patients. Herein, we reported three patients with R/R AML who w...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bin-Ru, Wan, Chao-Ling, Liu, Song-Bai, Qiu, Qiao-Cheng, Wu, Tian-Mei, Wang, Jun, Li, Yan-Yan, Ge, Shuai-Shuai, Qiu, Yan, Shen, Xiang-Dong, Xue, Sheng-Li, Li, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695792/
https://www.ncbi.nlm.nih.gov/pubmed/34956909
http://dx.doi.org/10.3389/fonc.2021.797941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695792/
https://www.ncbi.nlm.nih.gov/pubmed/34956909
http://dx.doi.org/10.3389/fonc.2021.797941

Ejemplares similares